EUVIMEDEUVIMED entdecken
Crossref

[ 68 Ga]Ga-PG2-2FAPI: A DPro-Gly-Modified Dimeric FAPI Probe with Enhanced Tumor Uptake and Retention

Qing Ruan iD, Yuhao Jiang iD, Zuojie Li iD, Xiaojiang Duan, Lina Diao, Dajie Ding, Peiwen Han, Guangxing Yin, Jianyong Jiang, Junbo Zhang iD

Molecular Pharmaceutics · 2026

DOI: 10.1021/acs.molpharmaceut.5c01824 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Qing Ruan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Beam Technology of the Ministry of Education, School of Physics and Astronomy, Beijing Normal University, Beijing 100875, P.R. Chin…. Hauptthemen laut MEDLINE: Gallium Radioisotopes, Radiopharmaceuticals, Membrane Proteins. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Natural Science Foundation of Beijing Municipality, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, a novel fibroblast activation protein (FAP) targeting ligand based on the bivalent DPro-Gly structure, DOTA-PG2-2FAPI, was designed and synthesized. Molecular docking analysis revealed that compared with monomeric FAPI-46, DOTA-PG2-2FAPI had a higher binding score (-15.00 vs -11.36), with an in vitro IC50 value of 6.65 nM, indicating a significantly increased binding affinity toward FAP. The 68Ga-labeled complex ([68Ga]Ga-PG2-2FAPI) demonstrated radiochemical purity exceeding 95% with good stability and high hydrophilicity (LogD7.4 = -3.29 ± 0.06). In HT-1080-FAP cells, the cellular uptake of [68Ga]Ga-PG2-2FAPI reached 10.98 ± 0.10% ID, which decreased by 92% upon FAP inhibition. In vivo studies using tumor-bearing mice revealed that the tumor uptake of [68Ga]Ga-PG2-2FAPI was 17.60 ± 1.33% ID/g in HT-1080-FAP tumors and 32.71 ± 0.98% ID/g in U87MG tumors, which was significantly greater than that in nontargeted tissues. Positron emission tomography (PET) imaging revealed rapid tumor accumulation and sustained retention, with high-specificity imaging across all four tumor models (HT-1080-FAP, U87MG, HT-29, and PANC-1). On the basis of these characteristics, this probe holds promise as a broad-spectrum tumor imaging agent with significant clinical application value.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gallium RadioisotopesRadiopharmaceuticalsMembrane ProteinsAnimalsHumansMiceCell Line, TumorFibroblast Activation Protein AlphaSerine EndopeptidasesMolecular Docking SimulationEndopeptidasesPositron-Emission TomographyTissue DistributionMice, NudeFemaleQuinolines

Stichwörter der Autor:innen

68GaDPro-Gly linkerFAPPETdimeric probe

Substanzen

Gallium RadioisotopesFibroblast Activation Protein AlphaSerine EndopeptidasesEndopeptidasesRadiopharmaceuticals68Ga-FAPIMembrane ProteinsQuinolines

Autor:innen und Institutionen

  • Key Laboratory of Beam Technology of the Ministry of Education, School of Physics and Astronomy, Beijing Normal University, Beijing 100875, P.R. China.
  • Key Laboratory of Radiopharmaceuticals of the Ministry of Education, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), College of Chemistry, Beijing Norm…
  • Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, P.R. China.

ORCID-Profile: Qing Ruan, Yuhao Jiang, Zuojie Li, Junbo Zhang

Förderung

  • Natural Science Foundation of Beijing Municipality
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • Beijing Nova Program

Zitieren

APA

Ruan, Q., Jiang, Y., Li, Z., Duan, X., Diao, L., Ding, D., Han, P., Yin, G., Jiang, J., & Zhang, J. (2026). [ 68 Ga]Ga-PG2-2FAPI: A DPro-Gly-Modified Dimeric FAPI Probe with Enhanced Tumor Uptake and Retention. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01824

Vancouver

Ruan Q, Jiang Y, Li Z, Duan X, Diao L, Ding D, et al. [ 68 Ga]Ga-PG2-2FAPI: A DPro-Gly-Modified Dimeric FAPI Probe with Enhanced Tumor Uptake and Retention. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c01824

BibTeX
@article{Ruan2026,
  author = {Ruan, Qing and Jiang, Yuhao and Li, Zuojie and Duan, Xiaojiang and Diao, Lina and Ding, Dajie and Han, Peiwen and Yin, Guangxing and Jiang, Jianyong and Zhang, Junbo},
  title = {[ 68 Ga]Ga-PG2-2FAPI: A DPro-Gly-Modified Dimeric FAPI Probe with Enhanced Tumor Uptake and Retention},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  doi = {10.1021/acs.molpharmaceut.5c01824}
}
Kostenlos starten →